MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol

Despite progress in the treatment of head and neck squamous cell carcinoma (HNSCC) in recent decades, including new surgical techniques, radiotherapy advances and chemotherapy schedules, the prognosis for the affected patients has not improved at the same pace, and still, most HNSCC patients are dia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Arantes, Lidia Maria Rebolho Batista, Laus, Ana Carolina, Melendez, Matias Eliseo, de Carvalho, Ana Carolina, Sorroche, Bruna Pereira, De Marchi, Pedro Rafael Martins, Evangelista, Adriane Feijó, Scapulatempo-Neto, Cristovam, de Souza Viana, Luciano, Carvalho, André Lopes
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354780/
https://ncbi.nlm.nih.gov/pubmed/28039483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14253
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky